Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Thomas Campbell

Concepts (644)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Sarcoma, Kaposi
27
2026
83
6.970
Why?
HIV Infections
116
2026
3154
6.400
Why?
HIV-1
61
2023
896
4.280
Why?
Anti-HIV Agents
47
2024
888
3.580
Why?
Herpesvirus 8, Human
22
2024
68
3.200
Why?
Antiretroviral Therapy, Highly Active
30
2023
278
2.430
Why?
AIDS-Related Opportunistic Infections
14
2026
130
1.950
Why?
Anti-Retroviral Agents
21
2024
250
1.690
Why?
Zimbabwe
21
2026
76
1.620
Why?
Acquired Immunodeficiency Syndrome
7
2023
235
1.330
Why?
Viral Load
34
2023
526
1.310
Why?
HIV Seropositivity
7
2021
119
1.280
Why?
Biomarkers, Tumor
3
2026
1322
1.230
Why?
International Cooperation
4
2018
198
1.120
Why?
CD4 Lymphocyte Count
26
2023
277
1.000
Why?
Inflammation
17
2026
2880
0.990
Why?
Aging
9
2024
1966
0.940
Why?
Education, Medical
3
2018
276
0.930
Why?
alpha 1-Antichymotrypsin
1
2025
4
0.890
Why?
Adult
103
2026
40506
0.870
Why?
Gastrointestinal Microbiome
8
2026
771
0.850
Why?
Middle Aged
79
2026
35928
0.850
Why?
RNA, Viral
19
2014
688
0.820
Why?
Humans
169
2026
144957
0.790
Why?
Male
120
2026
72406
0.790
Why?
Physical Fitness
2
2015
209
0.790
Why?
Lung Neoplasms
3
2026
2642
0.780
Why?
DNA, Viral
12
2013
358
0.750
Why?
Female
113
2026
78376
0.730
Why?
Tuberculosis
7
2023
291
0.720
Why?
Drug Resistance, Viral
8
2015
123
0.700
Why?
Herpesviridae Infections
7
2021
150
0.690
Why?
Viremia
6
2011
158
0.690
Why?
Antibodies, Viral
8
2023
672
0.670
Why?
AIDS Dementia Complex
7
2015
52
0.650
Why?
Antibiotics, Antineoplastic
4
2026
139
0.640
Why?
Coinfection
6
2019
141
0.640
Why?
CD4-Positive T-Lymphocytes
12
2023
1129
0.630
Why?
Granulocyte Colony-Stimulating Factor
4
2004
89
0.610
Why?
Reverse Transcriptase Inhibitors
6
2015
87
0.600
Why?
Nursing Staff, Hospital
1
2022
158
0.600
Why?
Lamivudine
6
2017
65
0.590
Why?
Hematopoietic Stem Cell Mobilization
3
2004
27
0.580
Why?
Lipopolysaccharide Receptors
2
2021
87
0.580
Why?
Homosexuality, Male
6
2026
222
0.570
Why?
Anemia
3
2023
188
0.560
Why?
Vitamin D Deficiency
3
2017
186
0.560
Why?
Breast Neoplasms
3
2026
2456
0.550
Why?
HIV
8
2023
250
0.540
Why?
Vitamin D
5
2018
400
0.530
Why?
Mass Screening
1
2026
1348
0.510
Why?
Plasma
4
2015
225
0.500
Why?
Prospective Studies
23
2026
7997
0.500
Why?
Micronutrients
4
2018
96
0.490
Why?
1-Alkyl-2-acetylglycerophosphocholine Esterase
2
2023
24
0.490
Why?
Health Resources
5
2019
130
0.480
Why?
Biomarkers
14
2026
4275
0.480
Why?
Internationality
5
2019
156
0.470
Why?
Motor Activity
3
2015
722
0.460
Why?
RNA, Catalytic
4
1997
189
0.450
Why?
Burnout, Professional
1
2022
484
0.440
Why?
Benzoxazines
6
2017
31
0.430
Why?
Developing Countries
10
2020
318
0.430
Why?
Awareness
1
2015
110
0.430
Why?
Cardiotoxicity
2
2026
33
0.430
Why?
Zidovudine
7
2017
77
0.420
Why?
Quality of Life
6
2019
3192
0.410
Why?
HIV Integrase Inhibitors
1
2015
78
0.410
Why?
C-Reactive Protein
5
2015
417
0.400
Why?
Bronchoalveolar Lavage Fluid
6
2021
636
0.400
Why?
Monocytes
2
2023
538
0.400
Why?
Cytomegalovirus Infections
1
2015
206
0.390
Why?
South America
8
2026
57
0.380
Why?
Prevotella
2
2025
26
0.370
Why?
Immune Reconstitution Inflammatory Syndrome
4
2020
20
0.370
Why?
Doxorubicin
2
2026
397
0.360
Why?
Disease Progression
11
2025
2852
0.360
Why?
Treatment Outcome
22
2023
11695
0.360
Why?
Aged
24
2025
25947
0.360
Why?
Sarcopenia
1
2013
91
0.350
Why?
Receptors, CCR5
5
2021
60
0.350
Why?
Malnutrition
3
2018
86
0.350
Why?
Case-Control Studies
9
2025
3608
0.340
Why?
Pharmacogenetics
4
2026
173
0.320
Why?
Prevalence
10
2026
2836
0.320
Why?
Faculty, Medical
4
2018
303
0.320
Why?
Osteoporosis
1
2013
236
0.320
Why?
Africa
6
2020
116
0.310
Why?
Antineoplastic Agents, Phytogenic
3
2020
177
0.310
Why?
Neutropenia
1
2010
155
0.310
Why?
Accidental Falls
1
2012
222
0.300
Why?
Antiviral Agents
5
2017
768
0.300
Why?
Drug Therapy, Combination
10
2020
1048
0.300
Why?
Virus Replication
6
2006
529
0.300
Why?
Sexual Behavior
4
2020
492
0.300
Why?
Cross-Sectional Studies
10
2022
5872
0.290
Why?
Tenofovir
6
2017
295
0.290
Why?
Longitudinal Studies
10
2026
2947
0.290
Why?
Thrombocytopenia
1
2010
205
0.280
Why?
Randomized Controlled Trials as Topic
9
2025
1721
0.280
Why?
Emergency Medical Services
1
2015
696
0.280
Why?
Advance Care Planning
1
2012
243
0.280
Why?
Viral Proteins
2
2008
355
0.270
Why?
Genetic Variation
4
2008
984
0.270
Why?
Etoposide
4
2023
167
0.260
Why?
Professional Competence
2
2018
98
0.260
Why?
Microbiota
4
2018
781
0.260
Why?
Sex Characteristics
3
2023
791
0.260
Why?
Atazanavir Sulfate
3
2016
42
0.260
Why?
Health Services Accessibility
1
2015
1099
0.250
Why?
Cohort Studies
20
2019
5965
0.250
Why?
Cyclopropanes
6
2017
83
0.250
Why?
Incidence
9
2026
2883
0.250
Why?
Sexual and Gender Minorities
3
2021
251
0.250
Why?
Alkynes
6
2017
66
0.250
Why?
Schools, Medical
2
2018
157
0.250
Why?
Survival Analysis
4
2015
1385
0.250
Why?
Health Knowledge, Attitudes, Practice
1
2015
1416
0.250
Why?
Drug Monitoring
1
2010
395
0.250
Why?
Risk Factors
18
2025
10792
0.250
Why?
Macrophages, Alveolar
2
2020
368
0.250
Why?
Asia
5
2016
70
0.240
Why?
Feces
5
2025
513
0.230
Why?
CD8-Positive T-Lymphocytes
4
2021
917
0.230
Why?
Treatment Failure
8
2018
365
0.230
Why?
Sex Factors
4
2016
2114
0.230
Why?
Genotype
7
2023
1835
0.230
Why?
Drug Resistance, Multiple, Viral
1
2005
10
0.230
Why?
Pregnancy Complications, Infectious
3
2018
428
0.220
Why?
Needs Assessment
2
2018
404
0.220
Why?
Young Adult
19
2023
14126
0.220
Why?
Body Composition
2
2020
706
0.220
Why?
Bronchoscopy
1
2026
227
0.210
Why?
Proportional Hazards Models
7
2018
1325
0.210
Why?
Immune System Diseases
1
2004
39
0.210
Why?
Virus Latency
1
2004
90
0.210
Why?
Salvage Therapy
1
2005
162
0.210
Why?
Xenobiotics
1
2024
32
0.210
Why?
Dideoxynucleosides
2
2014
24
0.210
Why?
Lymph Nodes
3
2011
502
0.200
Why?
Curriculum
4
2018
1060
0.200
Why?
Bleomycin
2
2026
253
0.190
Why?
Insulin-Like Growth Factor I
2
2017
319
0.190
Why?
Program Evaluation
2
2018
949
0.190
Why?
Heart Injuries
1
2023
42
0.190
Why?
Interleukin-10
2
2023
310
0.190
Why?
Urban Population
3
2026
491
0.190
Why?
ADP-ribosyl Cyclase 1
2
2013
43
0.180
Why?
Nevirapine
2
2013
18
0.180
Why?
Lung
8
2022
4109
0.180
Why?
Africa South of the Sahara
5
2026
53
0.180
Why?
Neurocognitive Disorders
2
2019
33
0.180
Why?
Plaque, Atherosclerotic
1
2023
60
0.180
Why?
Myocarditis
1
2023
102
0.180
Why?
Intestinal Mucosa
2
2021
676
0.180
Why?
Research Design
2
2025
1137
0.180
Why?
Lymphocytes
2
2023
382
0.180
Why?
Speech
1
2022
77
0.170
Why?
Personnel Turnover
1
2022
42
0.170
Why?
Immunogenicity, Vaccine
1
2021
36
0.170
Why?
United States
9
2023
15988
0.170
Why?
Surveys and Questionnaires
5
2022
6053
0.170
Why?
Polymerase Chain Reaction
6
2021
1054
0.170
Why?
Emtricitabine
4
2017
205
0.170
Why?
Adolescent
16
2023
22453
0.170
Why?
Amyotrophic Lateral Sclerosis
1
2022
99
0.170
Why?
Gastrointestinal Tract
2
2014
208
0.170
Why?
B-Cell Maturation Antigen
1
2021
15
0.170
Why?
Selenium
3
2018
49
0.170
Why?
Multivariate Analysis
4
2015
1540
0.170
Why?
Cognition
4
2017
1269
0.160
Why?
Thinking
1
2021
66
0.160
Why?
Odds Ratio
2
2014
1077
0.160
Why?
Filgrastim
4
2004
13
0.160
Why?
T-Lymphocytopenia, Idiopathic CD4-Positive
1
2020
6
0.160
Why?
Intention
1
2022
183
0.160
Why?
Leukapheresis
1
2000
27
0.160
Why?
Pilot Projects
5
2014
1890
0.150
Why?
Pyridazines
2
2012
57
0.150
Why?
Hematopoietic Stem Cells
2
2000
420
0.150
Why?
Membrane Glycoproteins
2
2013
496
0.150
Why?
Workplace
1
2022
274
0.150
Why?
Vincristine
1
2020
140
0.150
Why?
Job Satisfaction
1
2022
240
0.150
Why?
Leadership
3
2018
409
0.150
Why?
Germ-Free Life
1
2019
33
0.150
Why?
Weight Loss
3
2020
837
0.150
Why?
Bacteria
3
2018
889
0.150
Why?
Peripheral Nervous System Diseases
1
2020
133
0.150
Why?
B-Lymphocytes
1
2004
877
0.150
Why?
Hexosaminidases
1
2019
16
0.150
Why?
Epigenesis, Genetic
1
2024
685
0.150
Why?
T-Lymphocytes, Regulatory
1
2021
389
0.140
Why?
Atherosclerosis
1
2023
409
0.140
Why?
DNA Methylation
1
2024
683
0.140
Why?
Exercise
2
2021
2201
0.140
Why?
Clinical Trials as Topic
2
2016
1054
0.140
Why?
Basal Ganglia
3
2014
57
0.140
Why?
Cerebral Cortex
2
2013
465
0.140
Why?
Paclitaxel
3
2026
256
0.140
Why?
Brain
4
2019
2941
0.140
Why?
Violence
1
2022
281
0.140
Why?
Diet
1
2026
1275
0.140
Why?
Organophosphonates
3
2013
97
0.140
Why?
Genes, pol
3
2007
7
0.140
Why?
Mouth
2
2015
88
0.140
Why?
Suicide
2
2017
720
0.140
Why?
Mutation
5
2016
4099
0.140
Why?
AIDS Vaccines
1
2018
52
0.140
Why?
Proteomics
1
2025
1195
0.130
Why?
HIV Protease Inhibitors
2
2016
69
0.130
Why?
Nucleic Acid Conformation
2
1997
726
0.130
Why?
Capacity Building
1
2018
62
0.130
Why?
Drug Combinations
2
2017
392
0.130
Why?
Vitamin A Deficiency
1
2017
26
0.130
Why?
Multiple Myeloma
1
2021
304
0.130
Why?
Immunotherapy, Adoptive
1
2021
337
0.130
Why?
Didanosine
2
2014
13
0.130
Why?
Early Detection of Cancer
1
2022
466
0.130
Why?
Herpesvirus 2, Human
1
2017
27
0.130
Why?
Inflammation Mediators
2
2018
509
0.130
Why?
Angiotensin Receptor Antagonists
1
2017
114
0.130
Why?
Follow-Up Studies
7
2021
5417
0.130
Why?
Financing, Organized
1
2017
36
0.120
Why?
Dysbiosis
2
2021
187
0.120
Why?
Anti-Inflammatory Agents
1
2020
475
0.120
Why?
Hospitals
1
2022
732
0.120
Why?
Brain Injuries, Traumatic
1
2023
441
0.120
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2017
222
0.120
Why?
Recombinant Proteins
4
2004
1371
0.120
Why?
Haiti
2
2016
14
0.120
Why?
Genes, env
2
2007
5
0.120
Why?
Coronary Artery Disease
1
2023
741
0.120
Why?
Adenine
3
2013
339
0.120
Why?
Lymphocyte Activation
3
2018
1126
0.120
Why?
Immunoglobulin G
2
2023
893
0.120
Why?
Magnetic Resonance Spectroscopy
3
2014
631
0.120
Why?
Kaplan-Meier Estimate
3
2013
966
0.120
Why?
Herpes Simplex
1
2017
98
0.120
Why?
Tetrahymena thermophila
1
1996
68
0.120
Why?
Nervous System Diseases
1
2019
284
0.120
Why?
Mental Status and Dementia Tests
1
2016
26
0.120
Why?
Ghana
1
2015
43
0.120
Why?
Up-Regulation
1
2019
852
0.120
Why?
TRPP Cation Channels
1
2016
74
0.120
Why?
Molecular Sequence Data
6
2013
2931
0.120
Why?
Cognitive Dysfunction
2
2019
464
0.120
Why?
Muscle Strength
1
2018
330
0.110
Why?
Ambulances
1
2015
53
0.110
Why?
DNA, Protozoan
1
2015
32
0.110
Why?
RNA, Protozoan
1
1995
60
0.110
Why?
Hepatitis B, Chronic
1
2015
22
0.110
Why?
Liver
1
2024
1888
0.110
Why?
Plasmodium falciparum
1
2015
39
0.110
Why?
Pregnancy Outcome
1
2018
476
0.110
Why?
Rhodobacter sphaeroides
3
1983
7
0.110
Why?
Chemokine CXCL10
1
2015
39
0.110
Why?
Military Personnel
1
2023
747
0.110
Why?
Cerebrospinal Fluid
1
2015
88
0.110
Why?
Clinical Competence
2
2021
1244
0.110
Why?
Retroviridae Infections
1
1995
47
0.110
Why?
Research
1
2018
431
0.110
Why?
Bone Morphogenetic Proteins
1
2015
142
0.110
Why?
Malaria
1
2015
73
0.110
Why?
Anthracyclines
1
2014
47
0.110
Why?
Cytomegalovirus
1
2015
168
0.100
Why?
Health Occupations
1
2014
36
0.100
Why?
Orchitis
1
2014
5
0.100
Why?
Penicillin G
1
2014
7
0.100
Why?
Caribbean Region
2
2011
30
0.100
Why?
Pre-Exposure Prophylaxis
1
2017
246
0.100
Why?
Time Factors
3
2015
7183
0.100
Why?
Health Care Surveys
1
2015
539
0.100
Why?
Exercise Therapy
1
2018
473
0.100
Why?
Stavudine
1
2013
6
0.100
Why?
Syphilis
1
2014
33
0.100
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2017
439
0.100
Why?
Phylogeny
3
2008
1019
0.100
Why?
Seroepidemiologic Studies
2
2015
172
0.100
Why?
Biota
1
2013
35
0.100
Why?
Tropheryma
1
2013
6
0.100
Why?
HIV Antigens
3
2015
17
0.100
Why?
Whipple Disease
1
2013
7
0.100
Why?
Insulin-Like Growth Factor Binding Protein 3
1
2013
32
0.100
Why?
Pyrrolidinones
1
2013
29
0.100
Why?
Aging, Premature
1
2013
16
0.100
Why?
Metabolic Diseases
1
2014
114
0.100
Why?
Genitalia, Male
1
2013
11
0.100
Why?
Body Fat Distribution
1
2013
45
0.100
Why?
Infectious Disease Transmission, Vertical
2
2012
193
0.100
Why?
Retinal Detachment
1
2014
73
0.100
Why?
Problem-Based Learning
1
2014
98
0.100
Why?
Peptide Fragments
3
2007
699
0.100
Why?
Education, Medical, Graduate
1
2018
557
0.100
Why?
Genitalia, Female
1
2013
42
0.100
Why?
Hospitals, University
1
2013
176
0.100
Why?
Sequence Analysis, DNA
3
2013
824
0.090
Why?
Fever
2
2021
312
0.090
Why?
Genetic Therapy
1
1995
313
0.090
Why?
Pregnancy
5
2018
7191
0.090
Why?
Frail Elderly
1
2013
134
0.090
Why?
Suicidal Ideation
2
2017
577
0.090
Why?
Prostatitis
1
1992
17
0.090
Why?
Hepatitis B
1
2013
66
0.090
Why?
Aspergillosis
1
1992
23
0.090
Why?
Muscles
1
2013
333
0.090
Why?
Metagenome
1
2013
149
0.090
Why?
RNA Stability
1
2013
119
0.090
Why?
Heart Failure
1
2025
2323
0.090
Why?
Urinary Catheterization
1
1992
33
0.090
Why?
Weight Gain
1
2016
559
0.090
Why?
Respiratory System
1
2013
149
0.090
Why?
Movement
1
2014
294
0.090
Why?
Withholding Treatment
1
2012
81
0.090
Why?
Marijuana Smoking
1
2015
250
0.090
Why?
Universities
1
2014
452
0.090
Why?
Unsafe Sex
1
2012
61
0.090
Why?
Body Weight
1
2016
978
0.090
Why?
HIV Core Protein p24
3
2006
32
0.090
Why?
Confidence Intervals
1
2012
333
0.090
Why?
Catheters, Indwelling
1
1992
96
0.090
Why?
Echocardiography
2
2026
652
0.090
Why?
Tumor Necrosis Factor-alpha
3
2022
1217
0.090
Why?
Exanthema
1
2012
84
0.090
Why?
Lipopolysaccharides
1
2015
863
0.090
Why?
Pulmonary Disease, Chronic Obstructive
1
2019
923
0.080
Why?
Education, Medical, Undergraduate
1
2014
207
0.080
Why?
Neuropsychological Tests
4
2019
1137
0.080
Why?
CD4 Antigens
1
2011
139
0.080
Why?
Smoking
2
2020
1472
0.080
Why?
Polyneuropathies
1
2011
57
0.080
Why?
Corpus Callosum
1
2011
72
0.080
Why?
Americas
1
2010
26
0.080
Why?
Mycobacterium tuberculosis
2
2012
337
0.080
Why?
Piperazines
1
1993
381
0.080
Why?
T-Lymphocyte Subsets
2
2011
415
0.080
Why?
Veterans
1
2023
1603
0.080
Why?
HLA-DR Antigens
1
2011
220
0.080
Why?
Kidney Diseases
1
2014
427
0.080
Why?
Bone and Bones
1
2013
315
0.080
Why?
Body Mass Index
3
2014
2438
0.080
Why?
RNA, Ribosomal, 16S
3
2019
559
0.080
Why?
Patient Compliance
1
2014
589
0.080
Why?
Fluorescent Antibody Technique
3
2015
370
0.080
Why?
Antigens, Viral
2
2021
182
0.080
Why?
HIV Reverse Transcriptase
2
2004
31
0.080
Why?
Interleukin-6
3
2022
780
0.080
Why?
Endothelial Cells
2
2024
870
0.080
Why?
Specimen Handling
1
2011
186
0.080
Why?
HIV Fusion Inhibitors
2
2007
3
0.080
Why?
HIV Envelope Protein gp41
2
2007
11
0.080
Why?
Tuberculosis, Pulmonary
2
2013
131
0.070
Why?
Bone Density
1
2013
482
0.070
Why?
Health Personnel
1
2016
748
0.070
Why?
Emigrants and Immigrants
1
2012
158
0.070
Why?
Smokers
2
2020
137
0.070
Why?
Metabolic Syndrome
1
2012
354
0.070
Why?
Neuroimaging
1
2011
292
0.070
Why?
RNA
1
1995
940
0.070
Why?
Epitopes, T-Lymphocyte
2
2006
175
0.070
Why?
Uganda
1
2008
93
0.070
Why?
Lung Diseases
1
2015
787
0.070
Why?
South Africa
3
2016
261
0.070
Why?
Leukocytes, Mononuclear
2
2021
573
0.070
Why?
Cytokines
3
2021
2065
0.070
Why?
Socioeconomic Factors
1
2012
1327
0.070
Why?
Base Composition
2
1997
82
0.060
Why?
Sweating
1
2007
41
0.060
Why?
Blood Vessels
1
2008
171
0.060
Why?
Amino Acid Sequence
3
2006
2157
0.060
Why?
Organizational Culture
2
2018
162
0.060
Why?
Vitamin A
2
2018
59
0.060
Why?
Healthy Volunteers
2
2018
215
0.060
Why?
Colorado
3
2012
4564
0.060
Why?
Purine Nucleosides
1
2006
4
0.060
Why?
Dioxolanes
1
2006
6
0.060
Why?
Gender Identity
1
2007
121
0.060
Why?
Peru
2
2016
62
0.060
Why?
Gene Products, gag
1
2006
38
0.060
Why?
Program Development
2
2018
370
0.060
Why?
Substrate Specificity
2
1997
392
0.060
Why?
DNA, Bacterial
3
2019
342
0.060
Why?
Biopsy
2
2020
1077
0.060
Why?
Phospholipids
3
1983
213
0.060
Why?
Retrospective Studies
4
2023
17101
0.060
Why?
Logistic Models
3
2015
2119
0.060
Why?
Selection Bias
1
2005
38
0.060
Why?
Disease Reservoirs
1
2004
25
0.050
Why?
Hypoalbuminemia
1
2024
28
0.050
Why?
Dizziness
2
2018
101
0.050
Why?
HIV Protease
1
2004
4
0.050
Why?
Hepatocyte Nuclear Factor 4
1
2024
15
0.050
Why?
HIV Envelope Protein gp120
1
2004
55
0.050
Why?
Linear Models
3
2011
854
0.050
Why?
Comorbidity
1
2009
1660
0.050
Why?
Double-Blind Method
3
2018
2029
0.050
Why?
WT1 Proteins
1
2024
12
0.050
Why?
CASP8 and FADD-Like Apoptosis Regulating Protein
1
2024
19
0.050
Why?
Base Sequence
3
1996
2191
0.050
Why?
Syndrome
1
2004
380
0.050
Why?
Castleman Disease
1
2003
16
0.050
Why?
Matrix Metalloproteinase 2
1
2023
56
0.050
Why?
Animals
7
2024
38109
0.050
Why?
Aspartic Acid
2
2014
88
0.050
Why?
Glucuronosyltransferase
1
2023
18
0.050
Why?
Endemic Diseases
1
2003
33
0.050
Why?
Anti-Bacterial Agents
1
2014
1915
0.050
Why?
Receptors, Tumor Necrosis Factor
1
2023
163
0.050
Why?
Hospitalization
2
2025
2434
0.050
Why?
Reference Values
2
2016
798
0.050
Why?
United Kingdom
2
2014
338
0.050
Why?
Polymorphism, Single Nucleotide
2
2023
2147
0.050
Why?
Speech Intelligibility
1
2022
4
0.050
Why?
Speech Production Measurement
1
2022
12
0.050
Why?
Binding Sites
2
1996
1331
0.050
Why?
Choline
2
2014
136
0.050
Why?
Lip
1
2022
22
0.050
Why?
Interferon-gamma
1
2006
784
0.050
Why?
Jaw
1
2022
27
0.050
Why?
Protein Isoforms
1
2024
402
0.050
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2004
983
0.050
Why?
Tongue
1
2022
76
0.040
Why?
Lopinavir
2
2013
30
0.040
Why?
Chemoradiotherapy
1
2023
239
0.040
Why?
Risk Assessment
2
2025
3676
0.040
Why?
Intention to Treat Analysis
1
2021
80
0.040
Why?
Ritonavir
2
2013
75
0.040
Why?
Magnetic Resonance Imaging
2
2011
3869
0.040
Why?
Deoxycytidine
2
2014
221
0.040
Why?
Ligands
1
2023
674
0.040
Why?
Patient Acuity
1
2021
47
0.040
Why?
Immunization, Secondary
1
2021
91
0.040
Why?
Frontal Lobe
2
2014
160
0.040
Why?
Receptors, Tumor Necrosis Factor, Type II
1
2021
41
0.040
Why?
Vidarabine
1
2021
32
0.040
Why?
Rural Population
1
2026
650
0.040
Why?
Cardiovascular Diseases
1
2013
2171
0.040
Why?
Receptors, Tumor Necrosis Factor, Type I
1
2021
81
0.040
Why?
Hemoglobins
1
2023
384
0.040
Why?
Regression Analysis
2
2014
1003
0.040
Why?
T-Lymphocytes, Cytotoxic
1
2001
177
0.040
Why?
Reproducibility of Results
3
2008
3415
0.040
Why?
Vascular Endothelial Growth Factor A
1
2023
557
0.040
Why?
Single-Blind Method
1
2021
312
0.040
Why?
Antibodies, Neutralizing
1
2023
341
0.040
Why?
Prognosis
2
2026
4293
0.040
Why?
Cyclophosphamide
1
2021
266
0.040
Why?
Cell Line
3
2001
2882
0.040
Why?
Cells, Cultured
4
2008
4155
0.040
Why?
Integrin alpha Chains
1
2020
22
0.040
Why?
Sensitivity and Specificity
2
2007
1990
0.040
Why?
Cough
1
2021
124
0.040
Why?
Enzyme-Linked Immunosorbent Assay
2
2015
851
0.040
Why?
Antigens, CD34
1
2000
88
0.040
Why?
Fatty Acids
1
1983
452
0.040
Why?
Genome, Bacterial
1
2021
156
0.040
Why?
Virion
1
2000
111
0.040
Why?
Brazil
2
2016
180
0.040
Why?
Immunophenotyping
1
2020
322
0.040
Why?
Immunologic Memory
1
2001
366
0.040
Why?
Tumor Microenvironment
1
2024
735
0.040
Why?
Biomechanical Phenomena
1
2022
842
0.040
Why?
Nitriles
2
2012
205
0.040
Why?
Diffusion Tensor Imaging
1
2019
73
0.040
Why?
Teacher Training
1
2018
10
0.030
Why?
Atrophy
1
2019
201
0.030
Why?
Aspartate Aminotransferases
1
2018
85
0.030
Why?
Genes, vpr
1
1997
1
0.030
Why?
Motor Skills
1
2019
104
0.030
Why?
Genes, vif
1
1997
3
0.030
Why?
Trace Elements
1
2018
52
0.030
Why?
Colony Count, Microbial
1
2018
122
0.030
Why?
Back Pain
1
2018
52
0.030
Why?
Cytochrome P-450 CYP2B6
1
2017
9
0.030
Why?
DNA Primers
2
1996
512
0.030
Why?
Stillbirth
1
2018
77
0.030
Why?
Cytochrome P-450 CYP2A6
1
2017
8
0.030
Why?
Macaca mulatta
1
2018
191
0.030
Why?
Adenoviridae
1
2018
199
0.030
Why?
Principal Component Analysis
1
2018
198
0.030
Why?
Immunity, Humoral
1
2018
120
0.030
Why?
In Vitro Techniques
1
2019
1048
0.030
Why?
Colon
1
2020
305
0.030
Why?
Diarrhea
1
2018
192
0.030
Why?
Genome-Wide Association Study
1
2024
1407
0.030
Why?
Abdominal Pain
1
2018
146
0.030
Why?
Toll-Like Receptors
1
2018
194
0.030
Why?
Genetic Vectors
1
2018
337
0.030
Why?
Seroconversion
1
2017
49
0.030
Why?
Antigens, CD
1
2020
555
0.030
Why?
Oligoribonucleotides
1
1996
52
0.030
Why?
Benzoxazoles
1
1996
20
0.030
Why?
Immunity, Cellular
1
2018
272
0.030
Why?
Ruthenium Red
1
2016
7
0.030
Why?
Amiloride
1
2016
25
0.030
Why?
Thailand
1
2016
18
0.030
Why?
Gene Frequency
1
2017
481
0.030
Why?
Life Style
1
2018
479
0.030
Why?
Malawi
1
2016
57
0.030
Why?
Immunosuppressive Agents
1
2021
847
0.030
Why?
Pyrimidines
2
2012
533
0.030
Why?
Fatigue
1
2018
366
0.030
Why?
Administration, Oral
1
2018
848
0.030
Why?
Patient Selection
1
2000
719
0.030
Why?
Age Factors
2
2016
3335
0.030
Why?
India
1
2016
218
0.030
Why?
Nutritional Status
1
2018
354
0.030
Why?
Catalysis
1
1996
322
0.030
Why?
Parasitemia
1
2015
15
0.030
Why?
Human Activities
1
2015
20
0.030
Why?
Verbal Learning
1
2016
73
0.030
Why?
pol Gene Products, Human Immunodeficiency Virus
1
2015
1
0.030
Why?
Hepatitis B virus
1
2015
33
0.030
Why?
Point Mutation
1
2016
243
0.030
Why?
Gene Knockdown Techniques
1
2016
336
0.030
Why?
Tetrahymena
1
1995
158
0.030
Why?
Placebos
1
2015
193
0.030
Why?
Carotenoids
1
2015
48
0.030
Why?
Genotyping Techniques
1
2015
69
0.030
Why?
RNA Splicing
1
1996
285
0.030
Why?
Pyridones
1
1996
199
0.030
Why?
Chronic Disease
2
2014
1813
0.030
Why?
Nuclear Proteins
1
1999
749
0.030
Why?
Vitamin E
1
2015
121
0.030
Why?
World Health Organization
1
2014
105
0.030
Why?
Vaccination
1
2023
1423
0.030
Why?
Schools, Health Occupations
1
2014
8
0.030
Why?
Genetic Markers
1
2015
331
0.030
Why?
Retreatment
1
2014
77
0.030
Why?
Premature Birth
1
2018
380
0.030
Why?
Developed Countries
1
2014
38
0.030
Why?
Mice
2
2024
18365
0.030
Why?
Ophthalmoscopy
1
2014
38
0.030
Why?
Fellowships and Scholarships
1
2018
357
0.030
Why?
Dose-Response Relationship, Drug
1
2018
2032
0.030
Why?
Creatine
1
2014
63
0.030
Why?
Psychology
1
2014
88
0.030
Why?
Diffusion of Innovation
1
2014
98
0.030
Why?
Group Processes
1
2014
64
0.020
Why?
Protons
1
2014
95
0.020
Why?
Educational Status
1
2016
467
0.020
Why?
Raltegravir Potassium
1
2013
18
0.020
Why?
DNA, Ribosomal
1
2013
94
0.020
Why?
Bronchoalveolar Lavage
1
2013
89
0.020
Why?
Inositol
1
2013
25
0.020
Why?
Gray Matter
1
2014
92
0.020
Why?
Skin
1
2018
758
0.020
Why?
Hepatitis B Surface Antigens
1
2013
17
0.020
Why?
Polymorphism, Genetic
1
2016
612
0.020
Why?
Phenotype
2
2014
3164
0.020
Why?
Kinetics
1
1996
1629
0.020
Why?
Mice, Inbred C57BL
1
2024
5997
0.020
Why?
Oligopeptides
1
2014
269
0.020
Why?
Programmed Cell Death 1 Receptor
1
2015
264
0.020
Why?
Polycystic Kidney, Autosomal Dominant
1
2016
235
0.020
Why?
Medication Adherence
1
2017
539
0.020
Why?
Global Health
1
2015
401
0.020
Why?
Risk
1
2015
911
0.020
Why?
Adaptor Proteins, Signal Transducing
1
2015
428
0.020
Why?
Gene Expression Regulation
2
2014
2609
0.020
Why?
White Matter
1
2014
154
0.020
Why?
Neurologic Examination
1
2012
131
0.020
Why?
Microbial Sensitivity Tests
1
1993
371
0.020
Why?
Cause of Death
1
2014
472
0.020
Why?
Hypertension, Pulmonary
1
2003
1980
0.020
Why?
Receptors, HIV
1
2011
23
0.020
Why?
Blood Coagulation
1
2013
268
0.020
Why?
Kidney Failure, Chronic
1
2017
598
0.020
Why?
Zebrafish
1
2016
528
0.020
Why?
Psychological Tests
1
2012
132
0.020
Why?
Data Collection
1
2014
635
0.020
Why?
Glutamic Acid
1
2013
251
0.020
Why?
Cooperative Behavior
1
2014
465
0.020
Why?
Flow Cytometry
1
2015
1173
0.020
Why?
Headache
1
2012
150
0.020
Why?
Mood Disorders
1
2012
140
0.020
Why?
Models, Theoretical
1
2014
582
0.020
Why?
Biological Specimen Banks
1
2011
103
0.020
Why?
Visual Acuity
1
2014
489
0.020
Why?
Mozambique
1
2010
7
0.020
Why?
Suicide, Attempted
1
2014
422
0.020
Why?
Pyridines
1
2014
605
0.020
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2020
1958
0.020
Why?
Calcium
1
2016
1184
0.020
Why?
Social Support
1
2014
652
0.020
Why?
North America
1
2011
310
0.020
Why?
Pyrimidinones
1
2010
126
0.020
Why?
Gene Expression
1
1995
1490
0.020
Why?
Statistics, Nonparametric
1
2010
427
0.020
Why?
T-Lymphocytes
1
2018
1982
0.020
Why?
Feasibility Studies
1
2014
1095
0.020
Why?
Neuroglia
1
2010
172
0.020
Why?
Antitubercular Agents
1
2011
216
0.020
Why?
Thalamus
1
2010
126
0.020
Why?
Students, Medical
1
2014
375
0.020
Why?
Multicenter Studies as Topic
1
2010
405
0.020
Why?
Organ Size
1
2010
463
0.020
Why?
Caspase 7
1
2008
22
0.020
Why?
Predictive Value of Tests
1
2014
2118
0.020
Why?
In Situ Nick-End Labeling
1
2008
121
0.020
Why?
Mental Health
1
2015
792
0.020
Why?
Bone Morphogenetic Protein 4
1
2008
43
0.020
Why?
Culture Media, Conditioned
1
2008
111
0.020
Why?
Sleep Wake Disorders
1
2012
302
0.020
Why?
Caspase 3
1
2008
238
0.020
Why?
T-Cell Antigen Receptor Specificity
1
2006
45
0.020
Why?
Fluorides
1
2006
49
0.020
Why?
Endothelium, Vascular
1
2013
965
0.020
Why?
Polyurethanes
1
2006
38
0.020
Why?
gag Gene Products, Human Immunodeficiency Virus
1
2006
10
0.010
Why?
Oligonucleotide Array Sequence Analysis
1
2008
758
0.010
Why?
Methacrylates
1
2006
119
0.010
Why?
Sequence Alignment
1
2006
368
0.010
Why?
Computer Simulation
1
2010
1026
0.010
Why?
Alleles
1
2007
881
0.010
Why?
Carrier Proteins
1
2008
737
0.010
Why?
Guanosine Tetraphosphate
1
1983
5
0.010
Why?
Cerulenin
1
1983
1
0.010
Why?
Linolenic Acids
1
1983
1
0.010
Why?
Linoleic Acids
1
1983
6
0.010
Why?
Oleic Acids
1
1983
12
0.010
Why?
Light
2
1983
411
0.010
Why?
Severity of Illness Index
1
2011
2925
0.010
Why?
Linoleic Acid
1
1983
44
0.010
Why?
Oleic Acid
1
1983
42
0.010
Why?
Nucleotides
1
1983
128
0.010
Why?
Fatty Acids, Unsaturated
1
1983
98
0.010
Why?
Membrane Lipids
1
1983
83
0.010
Why?
Models, Biological
1
2010
1822
0.010
Why?
Cytotoxicity Tests, Immunologic
1
2001
37
0.010
Why?
Bacteriological Techniques
1
1981
68
0.010
Why?
Aged, 80 and over
1
2013
8279
0.010
Why?
Cardiac Catheterization
1
2003
560
0.010
Why?
Apoptosis
1
2008
2430
0.010
Why?
Immunohistochemistry
1
2003
1718
0.010
Why?
HIV Seronegativity
1
1998
29
0.010
Why?
Infant
1
2012
10039
0.010
Why?
Substance Abuse, Intravenous
1
1998
128
0.010
Why?
Antipyrine
1
1996
12
0.010
Why?
Drug Resistance, Microbial
1
1996
70
0.010
Why?
Drug Interactions
1
1996
401
0.010
Why?
Cross-Over Studies
1
1996
601
0.010
Why?
Intracellular Membranes
1
1981
76
0.000
Why?
Cell Division
1
1981
766
0.000
Why?
Campbell's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)